GlassScriptPhysician profile
Kenneth M Ward
NPI 1386012086
$1,480.43
in general payments reported to CMS, 2019-2025
16 companies · $78.57 in 2025
The $78.57 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.05 · 2022: $403 · 2023: $725 · 2024: $261 · 2025: $78.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $265.57 | 2022-2023 | Krystexxa |
| Vifor Pharma, INC. | $259.20 | 2021-2023 | Veltassa |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $246.84 | 2023-2024 | |
| Glaxosmithkline, LLC. | $159.24 | 2023 | Jesduvroq |
| Otsuka America Pharmaceutical, INC. | $156.95 | 2022-2025 | Jynarque |
| Nxstage Medical, INC. | $89.12 | 2022-2024 | Nxstage Cartridge Express, Nxstage System One |
| Opko Pharmaceuticals, LLC | $48.68 | 2023 | Rayaldee |
| Btg International INC. | $47.51 | 2023-2025 | Voraxaze |
| Mallinckrodt Hospital Products INC. | $38.26 | 2023 | Terlivaz |
| Amgen INC. | $31.40 | 2024 | Krystexxa |
| Kyowa Kirin, INC. | $28.58 | 2024 | Crysvita |
| Ardelyx, INC. | $24.23 | 2023 | Ibsrela |
| Calliditas Therapeutics US INC. | $23.20 | 2023 | Tarpeyo |
| Baxter Healthcare | $22.35 | 2024 | Renal - Acute |
| Astrazeneca Pharmaceuticals LP | $21.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $17.32 | 2023 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.